Kimberly Blackwell
Chief Executive Officer at Zentalis Pharmaceuticals Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Zentalis Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Century Therapeutics Inc. June 20, 2024100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 1, 2024 | Zentalis Pharmaceuticals Inc. | Grant or award | +250,000 | — | — |
| Feb 1, 2024 | Zentalis Pharmaceuticals Inc. | Shares withheld for tax | −20,655 | $11.69 | $241,457 |
| Nov 13, 2023 | Zentalis Pharmaceuticals Inc. | Open-market purchase | +5,000 | $10.29 | $51,450 |
| Feb 1, 2023 | Zentalis Pharmaceuticals Inc. | Grant or award | +244,800 | — | — |
Questions about Kimberly Blackwell
What boards is Kimberly Blackwell on?
Kimberly Blackwell sits on the boards of Century Therapeutics Inc., Monte Rosa Therapeutics Inc. and Zentalis Pharmaceuticals Inc.
Has Kimberly Blackwell been a CEO?
Yes — Kimberly Blackwell was CEO of Zentalis Pharmaceuticals Inc. (Until November 2024).
How long has Kimberly Blackwell served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.